CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
737.95%
This Fund
S&P 500
1 Year Est. Return
+737.95%
AUM
$1.98B
AUM Growth
+$220M
(+12%)
Holding
52
Top Buys
| 1 | +$68.6M | |
| 2 | +$55M | |
| 3 | +$39.2M | |
| 4 |
AGMB
AgomAb Therapeutics NV
AGMB
|
+$34.9M |
| 5 |
MAZE
Maze Therapeutics
MAZE
|
+$33.1M |
Top Sells
| 1 | +$69.8M | |
| 2 | +$36.1M | |
| 3 | +$25.4M | |
| 4 |
Praxis Precision Medicines
PRAX
|
+$20M |
| 5 |
GH Research
GHRS
|
+$16.5M |
Sector Composition
| 1 | Healthcare | 99.34% |
| 2 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Invesco QQQ Trust
QQQ
$492B
| – | – |
0
|
|
||
52
State Street SPDR S&P Biotech ETF
XBI
$8.54B
| – | – |
0
|
|